CHEK 1 (-7.41%)
IL0011336851• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. CHEK

Check-Cap (CHEK) Competitor Comparison

We are evaluating the key criteria listed to compare Check-Cap (CHEK) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 56

Dividend yield

0 / 9

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Linearity 10 years - CHEK ranking 0 / 58

These are the competitors of Check-Cap in the industry Diagnostics & Research ranked by linearity 10 years
1. Guardant Health GH
226.69
2. Neogen NEOG
200.03
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. National Research NRC
25.13
5. Inotiv NOTV
23.09
6. Illumina ILMN
20.46
7. Olink Holding OLK
8.11
8. Global Cord Blood CO
5.67
9. Anixa Biosciences ANIX
5.55
10. Sotera Health SHC
5.06
11. Pacific Biosciences of California PACB
4.96
12. DarioHealth DRIO
4.86
13. Fulgent Genetics FLGT
4.8
14. Myriad Genetics MYGN
4.5
15. Bioventus BVS
4.12
16. Syneos Health SYNH
3.71
17. Sera Prognostics SERA
3.46
18. Exact Sciences EXAS
3.29
19. Co-Diagnostics CODX
3.22
20. Enzo Biochem ENZ
3.11
21. Qiagen QGEN
3
22. Psychemedics PMD
2.71
23. Twist Bioscience TWST
2.35
24. Aspira Womens Health AWH
2.28
25. NeoGenomics NEO
2.23
26. Exagen XGN
2.23
27. Meridian Bioscience VIVO
2.1
28. MDxHealth MDXH
2.03
29. Biodesix BDSX
1.96
30. MaxCyte MXCT
1.87
31. Personalis PSNL
1.86
32. CareDx CDNA
1.85
33. Prenetics Global PRE
1.79
34. bioAffinity Technologies BIAF
1.71
35. Organovo Holdings ONVO
1.66
36. Neuronetics STIM
1.62
37. Trinity Biotech TRIB
1.57
38. SeqLL SQL
1.42
39. Interpace Biosciences IDXG
1.3
40. Quest Diagnostics DGX
1.28
41. Charles River Laboratories CRL
1.24
42. DexCom DXCM
1.24
43. PerkinElmer PKI
1.15
44. Precipio PRPO
1.09
45. Laboratory Corp of America Holdings LH
1.07
46. Icon ICLR
1.05
47. Agilent Technologies A
0.91
48. IQVIA Holdings IQV
0.85
49. IDEXX Laboratories IDXX
0.71
50. Waters WAT
0.7
51. Mettler-Toledo MTD
0.69
52. Thermo Fisher Scientific TMO
0.61
53. Danaher DHR
0.59
54. Heska HSKA
0.52
55. RadNet RDNT
0.44
56. Natera NTRA
0.4
57. Lantheus Holdings LNTH
0.33
58. Medpace Holdings MEDP
0.25
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.